Jazz Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell JAZZ and other ETFs, options, and stocks.

About JAZZ

Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio.

CEO

Bruce C. Cozadd

CEOBruce C. Cozadd

Employees

2,800

Employees2,800

Headquarters

Dublin, Dublin

HeadquartersDublin, Dublin

Founded

2005

Founded2005

Employees

2,800

Employees2,800

JAZZ Key Statistics

Market cap

6.71B

Market cap6.71B

Price-Earnings ratio

14.76

Price-Earnings ratio14.76

Dividend yield

—

Dividend yield—

Average volume

842.08K

Average volume842.08K

High today

—

High today—

Low today

—

Low today—

Open price

$109.89

Open price$109.89

Volume

0.00

Volume0.00

52 Week high

$148.06

52 Week high$148.06

52 Week low

$95.49

52 Week low$95.49

JAZZ News

Seeking Alpha 4d

Jazz Pharmaceuticals succeeds in late-stage study of lung cancer treatment

Jazz Pharmaceuticals (NASDAQ:JAZZ) said on Monday that the company's late-stage study of Zepzelca in combination with atezolizumab in small cell lung cancer tre...

Analyst ratings

95%

of 19 ratings

Buy

94.7%

Hold

5.3%

Sell

People also own

Based on the portfolios of people who own JAZZ. This list is generated using Robinhood data, and it’s not a recommendation.